6533b7dbfe1ef96bd1270b3b
RESEARCH PRODUCT
The dual role of non-selective beta-blockers in cirrhotic patients: How do we know when Dr Jekyll turns into Mr Hyde?
Jean-paul CervoniBasile MouhatThierry ThevenotRomain Chopardsubject
medicine.medical_specialtyDual roleHepatologybusiness.industryLiver Cirrhosis AlcoholicInternal medicineAdrenergic beta-AntagonistsmedicineHumansBeta (finance)businessGastroenterologyFollow-Up Studiesyear | journal | country | edition | language |
---|---|---|---|---|
2021-01-02 | Liver international : official journal of the International Association for the Study of the Liver |